This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Nicolette C Ross
Introduction
Nicolette C Ross is a prominent inventor based in Jupiter, Florida. She has made significant strides in the field of therapeutic applications, particularly in addressing drug addiction and related behaviors. Her work focuses on the development of cyclic tetrapeptides that serve as kappa opioid receptor antagonists.
Latest Patents
Nicolette holds a patent for her invention titled "Cyclic tetrapeptides." This patent describes cyclic tetrapeptides that can be utilized in therapeutic applications for treating, inhibiting, and preventing drug addiction, drug use, or drug-seeking behavior in subjects. The invention is particularly relevant for individuals with a history of drug addiction. The drugs targeted by these cyclic tetrapeptides include cocaine, alcohol, amphetamines, methamphetamines, nicotine, and opiates, among others. Additionally, these compounds can be effective in treating stress-induced drug-seeking behavior.
Career Highlights
Nicolette C Ross is affiliated with the University of Kansas, where she contributes her expertise to research and development in the field of pharmacology. Her innovative work has garnered attention for its potential impact on public health and addiction treatment.
Collaborations
Nicolette collaborates with esteemed colleagues, including Jane V Aldrich and Santosh Shripad Kulkarni. Their combined efforts enhance the research and development of therapeutic solutions in addiction treatment.
Conclusion
Nicolette C Ross exemplifies the spirit of innovation in the field of therapeutic applications. Her contributions, particularly in the development of cyclic tetrapeptides, hold promise for addressing critical issues related to drug addiction and behavior.